News: Front Section

Columbia’s Science + Technology Group awards five new construction and renovation projects

North Reading, MA Columbia, the construction management firm, has provided the award of three new projects for its Science + Technology sector for clients including 24M Technologies, Corning and Nyobolt. Columbia has also completed biotech projects for Ratio Therapeutics in the Seaport and Remix Therapeutics in Watertown. The recently restructured Science + Technology Group is focused on the construction and renovation of biotechnology, pharmaceutical R&D, manufacturing, chemical, battery, semiconductor, robotics, healthcare, medical device, and tech spaces.

“Columbia’s Science + Technology Group is the natural evolution of our long-time work bringing science to life,” said Bill Olson, vice president | Science + Technology. “Columbia’s technical facility design excellence and flexible and innovative problem-solving have long supported extraordinary results. As we expand our reach within this impactful arena, we look forward to accomplishing even more complex and inventive projects.”

The Columbia Science + Technology Group builds upon the firm’s comprehensive portfolio of laboratories, manufacturing facilities, cleanrooms, pilot plants, warehouses, bulk chemical plants, biological processing facilities, and other related sites.

 The Science + Technology Group utilizes sophisticated building information modeling tools to deliver a safe and efficient project, and its ambitious work is supported by Columbia’s in-house Energy Division, ensuring that projects are sustainable and energy-efficient. Columbia works within the guidelines of ASME, ASHRAE, API, ANSI, OSHA, EPA, cGMP, AAALAC, and FDA regulations.

“We have built a robust internal staff structure comprised of an impressive team of subject matter experts with a team-oriented focus to execute all our clients’ project goals,” says James Wrisley, Operations Director | Science + Technology.

MORE FROM Front Section
Front Section

McEvoy of The Conrad Group brokers $2.9 million sale of industrial building

Hingham, MA The Conrad Group  has brokered the sale of 55 Research Rd., South Shore Park. The property consists of a 20,340 s/f single story manufacturing building on two acres of land.
READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
The doctor is in: How medical leases differ from retail and office spaces - by Brian Cafferty

The doctor is in: How medical leases differ from retail and office spaces - by Brian Cafferty

As healthcare facilities, often referred to as “Doc in a Box” clinics, increasingly move into traditional retail spaces, landlords are more frequently leasing to medical tenants. Unlike standard retail or office leases, medical facilities come with a unique set of considerations that must be carefully addressed to ensure a successful tenancy.
5 Questions to ask when  choosing a real estate broker - by Elizabeth Perez Barlett

5 Questions to ask when choosing a real estate broker - by Elizabeth Perez Barlett

>They say, “April showers bring May flowers,” but this season may bring more movement in the housing market as springtime is one of the most popular times for home buying and selling. Although spring is one of the strongest seasons for the residential market, it may not be all rosebuds and butterflies if you don’t have the right advisors.
It’s time to get creative with closed college campuses - by Christian Koulichkov

It’s time to get creative with closed college campuses - by Christian Koulichkov

Facing higher costs, shrinking enrollments, reduced state funding and severe demographic headwinds, many colleges and universities in New England and the Northeast are fighting for survival. The latest to lose the battle is the 150 + year old University of the Arts in
Newmark negotiates sale of  10 Liberty Sq. and 12 Post Office Sq.

Newmark negotiates sale of 10 Liberty Sq. and 12 Post Office Sq.

Boston, MA Newmark has completed the sale of 10 Liberty Sq. and 12 Post Office Sq. Newmark co-head of U.S. Capital Markets Robert Griffin and Boston Capital Markets executive vice chairman Edward Maher, vice chairman Matthew Pullen, executive managing director James Tribble,